Nasdaq

Integra LifeSciences to Release Q4 and Full Year 2024 Financial Results on February 25, 2025

Integra LifeSciences will announce Q4 and full-year 2024 results on February 25, 2025, with a conference call at 8:30 a.m. ET. Integra LifeSciences Holdings Corporation will announce its financial ...
Business Insider

Integra Lifesciences: Sell Rating Justified by Underwhelming Financials and Leadership Concerns

Craig Bijou, an analyst from Bank of America Securities, reiterated the Sell rating on Integra Lifesciences (IART – Research Report). The associated price target is $42.00. Craig Bijou has given his ...
Nasdaq

Integra LifeSciences to Release First Quarter 2025 Financial Results on May 5, 2025

Integra LifeSciences will announce Q1 2025 financial results on May 5, with a conference call at 8:30 a.m. ET. Integra LifeSciences Holdings Corporation will announce its first quarter 2025 financial ...
Seeking Alpha

Integra LifeSciences Reports First Quarter 2024 Financial Results

First quarter revenues of $368.9 million declined 3.1% on a reported basis and declined 2.5% on an organic basis compared to the prior year. Revenue increased 1.6% on an organic basis excluding Boston ...
Morningstar

INTEGRA REPORTS THIRD QUARTER 2025 RESULTS; STRONG PRODUCTION FROM FLORIDA CANYON MINE, RECORD ADJUSTED NET EARNINGS, AND IMPROVED FINANCIAL POSITION

(1) Non-GAAP financial measure. Refer to the "Non-GAAP Financial Measures" section of this news release. In Q3 2025, the Company mined 2.5M tonnes of ore from its open pit operations at Florida Canyon ...